All Perspectives

Partner David Greenberg was quoted on a series of patient lawsuits challenging the alleged use of artificial intelligence (AI) and algorithms by health insurers, commenting on the potential hazards of insurers using the technology.

The Consulate General of Finland featured Partner Jon Jurva, Finnish Honorary Consul in Chicago, highlighting his contributions to supporting diplomatic and cultural ties between Finland and the United States.

Government Relations Partner Elizabeth Horner will present on a panel titled “Drafting Legislation” in Washington, DC, on April 8, 2025, as part of a National Academies workshop.

AFS Automotive’s Franjo M. Dolenac appeared on a panel with alumnus, Rob Cohen of Vitu, at the New Motor Vehicle Board’s Roundtable held in Sacramento, California on April 27, 2025 to talk about late title transfers for used vehicles.

The US Department of Justice (DOJ) is planning a major reorganization of the Environment and Natural Resources Division (ENRD) that includes consolidating several sections within the division into other DOJ divisions, as well as eliminating field offices.

Health Care Partner Debra Albin-Riley will participate in a session titled “Emerging Medical Staff Trends” at the California Society for Healthcare Attorneys’ (CSHA) 2025 Annual Meeting & Spring Seminar on April 6, 2025.

Government Relations Co-Leader Jon Bouker will present at the 51st Annual DC History Conference on April 4, 2025.

Partner David Dubrow was quoted on the use of artificial intelligence in fraud in response to the US Securities and Exchange Commission’s (SEC) complaint against three individuals who allegedly use fake documents to defraud investors in municipal bonds.

The Trump Administration’s latest tariff announcements are set to send shockwaves through the fashion and retail sectors, potentially upending supply chains industry wide. Consumers can expect higher costs for their favorite apparel, footwear, handbags, and accessories.

The protection of intellectual property (IP) is vital in the fiercely competitive artificial intelligence (AI) industry, necessitating a deep understanding of how the complex IP framework can be effectively leveraged to safeguard technological innovations in this rapidly evolving sector.

Headlines that Matter for Companies and Executives in Regulated Industries

James Kim was quoted on how the Trump Administration’s new 25% tariffs on cars and auto parts are prompting automakers and suppliers to reassess the North American automotive supply chain.

President Trump recently announced new and increased tariffs affecting key construction materials. The on-again, off-again nature of the Trump Administration’s tariff measures are contributing to the economic uncertainty in the construction industry, including short- and long-term price escalation and supply instability.

On March 25, ArentFox Schiff obtained a renewed preliminary injunction in federal court in Iowa preventing the enforcement of an Iowa law providing for the removal of books from school and classroom libraries.

Right now, much about the world is uncertain. Risks posed by political changes dominate the headlines and also weigh heavily on many decisions made by businesses, their advisors, and their stakeholders.

As promised by the US Department of Treasury in early March, the Financial Crimes Enforcement Network (FinCEN) issued an interim final rule removing the requirement for US companies, their beneficial owners, and US persons to report beneficial ownership information (BOI) to FinCEN under the Corporate Transparency Act (CTA).

In a highly unusual move, on March 27, the US Food and Drug Association (FDA) issued a Drug Safety Notice that calls into question both pending and approved abbreviated new drug applications (ANDAs) and new drug applications (NDAs) that relied on bioequivalence studies conducted by Raptim Research Pvt. Ltd, a contract research organization based in Navi Mumbai, India.

ArentFox Schiff is pleased to announce that Partner David Grosso has been honored with DC Appleseed’s Lifetime Achievement award for his dedication to democracy and statehood for the District of Columbia.

As a further update to our alert from March 27, the Trump Administration began mass layoffs at US health agencies on April 1.

Stan Abramson will speak on the Legal Liability Panel at the Biological Products Industry Alliance’s (BPIA) 2025 Annual Meeting in Sacramento, California, on April 2, 2025. His work is focused on chemical, biological, and biotechnology products for agricultural, industrial, and consumer use.

On March 27, the US Securities and Exchange Commission (SEC) announced that it will no longer defend Biden-era regulations requiring large corporations to disclose the impacts of climate change on their businesses. This announcement follows a vote by the SEC’s three-member governing body to end its defense of the rule and comes amid industry complaints that the rule was an overstep of the SEC’s authority.

Right now, much about the world is uncertain. Risks posed by political changes dominate the headlines and also weigh heavily on many decisions made by corporations, their advisors, and their stakeholders.

Health Care Practice Leader Douglas A. Grimm was quoted by Relias Media, urging hospitals and health care providers to prepare for potential Immigration and Customs Enforcement raids at their locations, following the Trump administration’s revocation of policies that previously made hospitals off-limits for immigration enforcement.

Health Care Partner Hillary Stemple was recently quoted on how physicians and other providers can navigate visits from drug and device manufacturer representatives, highlighting the legal and ethical complexities involved.

This past year, in the wake of significant economic challenges facing the health care industry, an unprecedented number of receiverships were imposed upon skilled nursing facilities in Massachusetts. Historically, Massachusetts receiverships have been used sparingly as a tool to address distressed or insolvent situations, with bankruptcy being the favored option.